Berek Anna, Kindl Philipp, Schiefecker Alois J, Altmann Klaus, Putnina Lauma, Helbok Raimund, Pfausler Bettina, Beer Ronny, Rass Verena
Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Department of Neurology, Johannes Kepler University Linz, Linz, Austria.
Eur J Neurol. 2025 Jul;32(7):e70292. doi: 10.1111/ene.70292.
Frailty, defined as an age-related syndrome of multidimensional physiological decline, may serve as a valuable marker to identify brain-injured patients who are less likely to benefit from aggressive treatment, thus avoiding unnecessary interventions. Here we aimed to evaluate the predictive value of the Clinical Frailty Scale (CFS) score for functional outcome.
This retrospective study included 1008 patients admitted to the neurological intensive care unit (ICU), with ischemic and hemorrhagic stroke (subarachnoid hemorrhage, SAH and intracerebral hemorrhage, ICH), and traumatic brain injury (TBI). Outcome was evaluated with the modified Rankin Scale (mRS) at ICU discharge. Correlations and univariate analyses identified factors linked to higher CFS levels, while multivariable logistic regression evaluated CFS's potential to predict poor outcome (mRS ≥ 4).
Patients were admitted with ischemic stroke (n = 256, 25%), hemorrhagic stroke (n = 516, 51%) or TBI (n = 236, 23%) and the mean age was 66 years (IQR, 54-77). All disease severity grades were included, with a median GCS of 14 (9-15) at admission. The median premorbid CFS was 2 (1-3) with 9.2% of patients classified as frail (CFS ≥ 5). In multivariable analysis, CFS ≥ 5 was independently associated with poor outcome (adjOR [95% CI] 2.83 [1.50-5.33], p = 0.001). In a subgroup of patients aged ≥ 65 years (n = 532, 53%), a CFS-score of ≥ 5 was associated with poor outcome (adjOR [95% CI] 2.51 [1.24-5.09], p = 0.011), whereas age itself was not associated with poor outcome (p = 0.095).
Frailty as measured by the CFS remained a significant predictor of outcome, whereas age alone was not associated with poor outcome in patients aged ≥ 65 years.
衰弱被定义为一种与年龄相关的多维生理功能衰退综合征,它可能是一个有价值的指标,用于识别不太可能从积极治疗中获益的脑损伤患者,从而避免不必要的干预。在此,我们旨在评估临床衰弱量表(CFS)评分对功能预后的预测价值。
这项回顾性研究纳入了1008名入住神经重症监护病房(ICU)的患者,包括缺血性和出血性卒中(蛛网膜下腔出血、SAH和脑出血、ICH)以及创伤性脑损伤(TBI)。在ICU出院时用改良Rankin量表(mRS)评估预后。相关性和单因素分析确定了与较高CFS水平相关的因素,而多变量逻辑回归评估了CFS预测不良预后(mRS≥4)的潜力。
患者入院时诊断为缺血性卒中(n = 256,25%)、出血性卒中(n = 516,51%)或TBI(n = 236,23%),平均年龄为66岁(四分位间距,54 - 77岁)。纳入了所有疾病严重程度等级,入院时格拉斯哥昏迷量表(GCS)中位数为14(9 - 15)。病前CFS中位数为2(1 - 3),9.2%的患者被归类为衰弱(CFS≥5)。在多变量分析中,CFS≥5与不良预后独立相关(调整后比值比[95%置信区间]2.83[1.50 - 5.33],p = 0.001)。在年龄≥65岁的患者亚组(n = 532,53%)中,CFS评分≥5与不良预后相关(调整后比值比[95%置信区间]2.51[1.24 - 5.09],p = 0.011),而年龄本身与不良预后无关(p = 0.095)。
通过CFS测量的衰弱仍然是预后的重要预测指标,而在年龄≥65岁的患者中,仅年龄与不良预后无关。